EMEA-001270-PIP01-12-M04
Key facts
| Invented name |
Tenkasi (previously Orbactiv)
|
| Active substance |
oritavancin diphosphate
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0498/2021
|
| PIP number |
EMEA-001270-PIP01-12-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of acute bacterial skin and skin structure infections
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Menarini International Operations Luxembourg S.A.
E-mail: prijli@menarini.it |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|